Bruker provides all the pieces to solve the 'metabolomics puzzle' with integrated and advanced technical solutions.
Metabolomic analysis must accurately determine even the slightest changes of molecular profile related to disease, disease progression, therapeutic intervention, genetic modification or environmental variation. Thanks to the latest innovations in hyphenated NMR, LC-MS, GC-MS and FT-IR technologies, Bruker remains the leader in integrated solutions for metabolomics.
Systems can be used for a broad variety of targeted and non-targeted metabolomics studies, well equipped to detect, identify and measure metabolome molecules covering the entire metabolomics chemical space.
Compass PathwayScreener adds a new layer of insight, letting users perform pathway-driven, targeted metabolomics analysis on the same dataset used for non-targeted data mining. The workflow integrates with Bruker's ProfileAnalysis platform for non-targeted metabolomics and label-free proteomics studies.
“Using Compass PathwayScreener we were able to elucidate novel influences of mutants on metabolic networks in Corynebacterium glutamicum.”